Phoenix Life Sciences International Limited announced that it has signed a binding Memorandum of Understanding (MOU) between the Company and the Ministry of Health on behalf of the Government of Vanuatu, located in the South Pacific. The MOU includes an exclusive 25-year diabetes management program, the creation of a national healthcare network, medical cannabis licensing and approval for Phoenix Life to export globally, both medical products for the targeted treatment of diabetes and generic medical cannabis products from the Republic of Vanuatu. With this agreement, Phoenix Life will work with the Ministry of Health to establish a National Network of Community Healthcare Clinics and Dispensing Pharmacies throughout the country to manage the national Type 2 diabetes epidemic for a minimum of the next 25 years. These clinics will also provide dispensing of Phoenix Life’s diabetes management product, Phoenix Metabolic, as an alternative to insulin for the nation’s forecast more than 50,000 type 2 diabetics and an expected 50,000 high risk pre-diabetics. Phoenix Life is authorized to conduct screenings throughout the Republic of Vanuatu, including at Vila Central Hospital, to assess health conditions such as blood sugar levels, hypertension and overall wellness, among Ni-Vanuatu citizens. The work done at these Community Healthcare Clinics and Dispensing Pharmacies and the Company’s screening locations will provide a platform for patient access. Additionally, as part of the agreement, Phoenix Life plans to develop training programs to educate medical professionals and support personnel on the best practices, uses of medical cannabis and improved management of type 2 diabetes and its complications. These programs will be created in conjunction with leading universities and colleges from the United States, Australia, New Zealand and The Republic of Vanuatu. Phoenix Life intends to make this same program available to Governments and their health agencies throughout the world, and more specifically to the least developed countries and developing countries that cannot afford insulin programs. By creating this affordable program to bring solutions to those suffering from type 2 diabetes and its complications to these countries and their people, Phoenix Life is positioning itself to address the health and wellness of millions of diabetics worldwide.